PRECIGEN Investors


64th American Society of Hematology (ASH) Annual Meeting and Exposition

Dec 12, 2022 at 6:00 PM - 8:00 PM CST

An abstract (Abstract# 4633) titled, "Phase 1/1b Safety Study of PRGN-3006 UltraCAR-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes," was presented as a poster presentation.

Supporting Materials